Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes

Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman

27-11-2024

https://doi.org/10.4081/btvb.2024.150

724

PDF: 156
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

https://doi.org/10.4081/btvb.2022.34

4578

PDF: 387

Supplementary Files: 116
Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

08-05-2024

https://doi.org/10.4081/btvb.2024.106

824

PDF: 324
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

23-05-2022

https://doi.org/10.4081/btvb.2022.12

4974

PDF: 301
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

09-03-2023

https://doi.org/10.4081/btvb.2023.53

680

PDF: 348
Allopurinol-induced acquired von Willebrand syndrome

Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

25-10-2023

https://doi.org/10.4081/btvb.2023.88

1582

PDF: 185
Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

29-10-2024

https://doi.org/10.4081/btvb.2024.156

1375

PDF: 263

Appendix: 186
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

03-08-2023

https://doi.org/10.4081/btvb.2023.90

1366

PDF: 454
The metaphor of Ukrainian science "bleeding"

Gaetano Torlone

04-04-2023

https://doi.org/10.4081/btvb.2023.73

301

PDF: 177
The intriguing association between cancer and congenital bleeding disorders

Ezio Zanon

16-12-2024

https://doi.org/10.4081/btvb.2024.146

183

PDF: 59
At the age of three

Giovanni de Gaetano, Chiara Cerletti

16-12-2024

https://doi.org/10.4081/btvb.2024.166

268

PDF: 78
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

16-05-2024

https://doi.org/10.4081/btvb.2024.115

675

PDF: 211
Author's Reply. Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial

Giovanni de Gaetano

05-12-2024

https://doi.org/10.4081/btvb.2024.163

538

PDF: 109
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

https://doi.org/10.4081/btvb.2024.114

486

PDF: 179
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1045

PDF: 330

APPENDIX: 67
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

17-10-2022

https://doi.org/10.4081/btvb.2022.40

2386

PDF: 223
Artificial intelligence, platelets and aspirin

Giovanni de Gaetano

15-03-2024

https://doi.org/10.4081/btvb.2024.130

391

PDF: 180
The changing landscape of treatment for acquired hemophilia A

Massimo Franchini, Daniele Focosi

30-01-2025

https://doi.org/10.4081/btvb.2025.157

788

PDF: 258
The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist

Alessandro Pezzini

21-08-2024

https://doi.org/10.4081/btvb.2024.151

1280

PDF: 340
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

27-06-2023

https://doi.org/10.4081/btvb.2023.84

1233

PDF: 280

Supplementary File: 151
Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

Marco Marietta, Giancarlo Castaman

27-05-2025

https://doi.org/10.4081/btvb.2025.180

628

PDF: 219
The new era of anticoagulation: factor XI and XII inhibitors

Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

07-06-2023

https://doi.org/10.4081/btvb.2023.76

2136

PDF: 857
Comments on "Da la scheggia rotta usciva insieme parole e sangue: an unusual case of bleeding and the metaphor of a clinical trial"

Jozef Vermylen

05-12-2024

https://doi.org/10.4081/btvb.2024.162

588

PDF: 107
Well begun is half done

Giovanni de Gaetano

14-12-2022

https://doi.org/10.4081/btvb.2022.61

1532

PDF: 158
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

29-02-2024

https://doi.org/10.4081/btvb.2024.111

1450

PDF: 307
The importance of rigorous and engaging scientific communication

Giovanni de Gaetano

14-05-2025

https://doi.org/10.4081/btvb.2025.191

162

PDF: 72
Gene transfer in hemophilia B: a big step forward

Giancarlo Castaman

17-05-2023

https://doi.org/10.4081/btvb.2023.70

868

PDF: 261
Stroke in women: anticoagulation in a complicated puzzle

Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

26-08-2024

https://doi.org/10.4081/btvb.2024.137

1075

PDF: 283
Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

Paolo Prandoni

11-10-2023

https://doi.org/10.4081/btvb.2023.97

1488

PDF: 224
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

https://doi.org/10.4081/btvb.2022.52

1983

PDF: 220
ReDIP, the Italian network for the diagnosis of congenital platelet function disorders

Marco Cattaneo, Claudia Ghali, Mariangela Scavone

22-04-2024

https://doi.org/10.4081/btvb.2024.134

352

PDF: 112
“Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

Giuseppe Auteri, Laura Ricci, Nicola Vianelli, Barbara Lovrencic

13-03-2025

https://doi.org/10.4081/btvb.2025.161

296

PDF: 119

Appendix A: 31

Appendix B: 37
A contribution from Umberto Veronesi Foundation

Chiara Tonelli

04-04-2023

https://doi.org/10.4081/btvb.2023.74

279

PDF: 136
Distal deep vein thrombosis: is there a way out of this dark forest?

Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

04-09-2024

https://doi.org/10.4081/btvb.2024.129

697

PDF: 219
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

15-04-2022

https://doi.org/10.4081/btvb.2022.9

653

PDF: 211

Supplementary Files: 68
Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

Bianca Clerici, Mariangela Scavone, Gian Marco Podda

20-06-2024

https://doi.org/10.4081/btvb.2024.127

1881

PDF: 508
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

Mosaad Almegren

12-10-2023

https://doi.org/10.4081/btvb.2023.85

319

PDF: 147
Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

24-03-2025

https://doi.org/10.4081/btvb.2025.155

175

PDF: 36
Science in Ukraine is “bleeding”

Giovanni de Gaetano

14-03-2023

https://doi.org/10.4081/btvb.2023.69

751

PDF: 200
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

https://doi.org/10.4081/btvb.2024.118

776

PDF: 301
Addressing some challenges of congenital fibrinogen disorders in 2023 and beyond

Cristina Santoro, Alessandro Casini

03-08-2023

https://doi.org/10.4081/btvb.2023.75

1108

PDF: 267
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

22-04-2024

https://doi.org/10.4081/btvb.2024.104

412

PDF: 131
How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

Anna Falanga, Hugo Ten Cate, Bianca Rocca

27-01-2023

https://doi.org/10.4081/btvb.2023.60

660

PDF: 298
Thrombotic thrombocytopenic purpura: much done, but still a lot to do

Paola Binetti

29-08-2024

https://doi.org/10.4081/btvb.2024.149

499

PDF: 170
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

https://doi.org/10.4081/btvb.2022.22

2007

PDF: 528
Welcome to AICE and sincere wishes for peace for the new year 2024

Giovanni de Gaetano

27-12-2023

https://doi.org/10.4081/btvb.2023.107

1242

PDF: 126
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

https://doi.org/10.4081/btvb.2024.144

863

PDF: 197

SUPPLEMENTARY MATERIAL: 92
The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

26-04-2022

https://doi.org/10.4081/btvb.2022.11

1996

PDF: 347

1 - 48 of 48 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy